Advertisement
CNC vs UNH
Which Stock Would AI Choose? Centene Corporation (CNC) vs. UnitedHealth Group (UNH) Stock Comparison
Key Takeaways
- CNC has delivered a stronger recent rebound, returning roughly 57% year to date, while UNH has gained roughly 14% over the same period.
- Centene's recovery is margin-driven, reflecting a return to profitability in recent quarters after a difficult 2025, whereas UnitedHealth's gains reflect steadier, diversified execution across insurance and its Optum services arm.
- UnitedHealth trades at a meaningfully higher valuation (a forward price-to-earnings ratio near 16.6) than Centene (near 12.4), reflecting its larger scale and lower volatility profile.
- Both companies face pressure in government-sponsored programs: Centene from shrinking Medicaid membership and UnitedHealth from Medicare Advantage enrollment declines and lower star ratings.
- UnitedHealth pays a dividend (yield near 2.5%), while Centene pays none, a key distinction for income-focused investors.
- The two stocks suit different profiles: Centene offers a higher-beta turnaround, while UnitedHealth offers a larger, more diversified, lower-beta franchise.
Introduction
Managed-care stocks rarely move in lockstep, and the recent divergence between Centene Corporation and UnitedHealth Group illustrates why a stock comparison between these two insurers matters for traders and investors alike. Both operate in the same U.S. healthcare sector and face common headwinds from medical-cost trends and government reimbursement changes, yet their market positioning, growth drivers, and risk profiles differ considerably. Centene is a government-sponsored care specialist staging an aggressive earnings recovery, while UnitedHealth is the sector's largest diversified player. This article examines their relative performance, business models, and sentiment so readers can better understand the trade-offs between a turnaround story and a defensive industry leader.
CNC Overview and Recent Performance
Centene Corporation is a managed-care company focused primarily on government-sponsored programs, including Medicaid, Medicare, and Affordable Care Act (ACA) Marketplace plans. After withdrawing 2025 guidance and posting losses tied to higher-than-expected medical costs, the company has staged a sharp turnaround. In its most recent quarter, Centene returned to profitability, reporting net income of about $1.09 billion and adjusted diluted earnings per share (EPS, or profit attributable to each share) of $2.51, versus a loss a year earlier. Its health benefits ratio (HBR, the share of premium revenue spent on medical care) improved to 89.6%, reflecting better pricing and cost discipline.
Investor sentiment has improved markedly in recent weeks. The stock has surged more than 55% year to date and roughly 117% over the past year, supported by raised guidance, debt redemption, and a stronger balance sheet. However, risks persist: Medicaid membership continues to decline and is expected to shrink 8% to 9% for the year, meaning the recovery leans heavily on margin improvement rather than top-line growth.
UNH Overview and Recent Performance
UnitedHealth Group is the largest U.S. health insurer and a diversified healthcare enterprise, combining its UnitedHealthcare insurance business with Optum, which spans pharmacy services, care delivery, and data analytics. In its latest quarter, the company beat expectations, posting adjusted EPS of $6.38, and raised its full-year 2026 adjusted EPS guidance to $19.50 to $20.00 while increasing planned share buybacks to at least $5 billion. Its medical care ratio (MCR, the equivalent of an HBR) improved to 86.7%, signaling stronger cost control.
Recent market activity has been more subdued. UnitedHealth shares rose strongly earlier in the year after a favorable Medicare Advantage payment update, but the stock has since pulled back roughly 17% from its July high as investors weighed a Medicare Advantage enrollment decline of about 1.1 million members and lower star ratings, which could create a revenue headwind in future years. The company also maintains a dividend yield near 2.5% and a lower beta (a measure of volatility relative to the market), reflecting its defensive, diversified profile.
Trending AI Robots
For investors who prefer a data-driven approach to navigating divergences like the one between these two insurers, Tickeron's Trending AI Robots page offers a curated view of its automated trading systems. Tickeron hosts hundreds of AI trading bots that collectively trade thousands of different tickers, each with its own trading style, strategy, timeframe, performance record, and statistical profile. Because not every bot suits every market, only the best-performing and most appropriate ones for current conditions earn a place in the Trending AI Robots section. Exploring this page can help traders identify systematically driven strategies aligned with today's market environment.
Head-to-Head Comparison
The clearest contrast is one of scale and focus. UnitedHealth generates roughly $450 billion in trailing revenue across a diversified mix of insurance and healthcare services, while Centene operates a more concentrated, government-sponsored model with revenue in the low-to-mid $190 billion range. This diversification gives UnitedHealth multiple growth drivers through Optum, whereas Centene's story hinges more directly on restoring underwriting margins in Medicaid and Marketplace plans.
Momentum and valuation also diverge sharply. Centene has been the stronger performer in recent months but trades at a discount, reflecting higher execution risk and membership uncertainty. UnitedHealth carries a premium multiple justified by its size, dividend, and lower beta, but its recent pullback and star-rating concerns have weighed on sentiment. In essence, Centene offers a higher-risk, higher-reward turnaround, while UnitedHealth offers steadier, diversified positioning with an income component and more moderate near-term catalysts.
Tickeron AI Verdict
Based on observable factors such as trend consistency, relative positioning, and catalysts, Tickeron's AI would likely favor CNC on a momentum and turnaround basis, given its stronger recent relative performance, improving margins, and the earnings-revision tailwind supporting its valuation re-rating. At the same time, UNH would likely screen more favorably on stability and diversification, thanks to its lower beta, dividend, and multi-segment earnings base. The optimal choice depends on the strategy's objective: trend-following models may lean toward Centene's rebound, while lower-risk, quality-oriented models may gravitate toward UnitedHealth's defensive profile.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNC is a Hold and UNH is a Hold.
CNC's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for CNC turned positive on October 06, 2026. Looking at past instances where CNC's MACD turned positive, the stock continued to rise in 31 of 49 cases over the following month. The odds of a continued upward trend are 63%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 06, 2026. You may want to consider a long position or call options on CNC as a result. In 56 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 62%.
CNC moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CNC crossed bullishly above the 50-day moving average on October 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 21 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 48%.
Following a +4.69% 3-day Advance, the price is estimated to grow further. Considering data from situations where CNC advanced for three days, in 188 of 307 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.
Bearish Trend Analysis
The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 63%.
CNC broke above its upper Bollinger Band on October 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for CNC entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 6 (best 1 - 100 worst), indicating outstanding price growth. CNC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 60 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 61 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CNC's P/B Ratio (1.369) is slightly lower than the industry average of (3.247). P/E Ratio (9.063) is within average values for comparable stocks, (139.958). Projected Growth (PEG Ratio) (0.754) is also within normal values, averaging (0.786). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (0.160) is also within normal values, averaging (0.569).
The Tickeron Profit vs. Risk Rating rating for this company is 91 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CNC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
The Tickeron SMR rating for this company is 95 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
UNH's Indicator enters downward trend
The Aroon Indicator for UNH entered a downward trend on October 12, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 123 similar instances where the Aroon Indicator formed such a pattern. In 81 of the 123 cases the stock moved lower. This puts the odds of a downward move at 66%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 41 of 63 cases where UNH's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 65%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UNH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 53%.
UNH broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where UNH's RSI Oscillator exited the oversold zone, 25 of 33 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 76%.
The Momentum Indicator moved above the 0 level on October 09, 2026. You may want to consider a long position or call options on UNH as a result. In 45 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 54%.
The Moving Average Convergence Divergence (MACD) for UNH just turned positive on October 05, 2026. Looking at past instances where UNH's MACD turned positive, the stock continued to rise in 25 of 46 cases over the following month. The odds of a continued upward trend are 54%.
UNH moved above its 50-day moving average on October 14, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +3.66% 3-day Advance, the price is estimated to grow further. Considering data from situations where UNH advanced for three days, in 187 of 335 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.445) is normal, around the industry mean (3.247). P/E Ratio (24.282) is within average values for comparable stocks, (139.958). Projected Growth (PEG Ratio) (1.025) is also within normal values, averaging (0.786). UNH has a moderately high Dividend Yield (0.024) as compared to the industry average of (0.009). P/S Ratio (0.757) is also within normal values, averaging (0.569).
The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 21 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating fairly steady price growth. UNH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 58 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 96 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UNH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
CNC | UNH | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 13 | 76 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 61 Fair valued | 4 Undervalued | |
PROFIT vs RISK RATING 1..100 | 91 | 96 | |
SMR RATING 1..100 | 95 | 58 | |
PRICE GROWTH RATING 1..100 | 6 | 47 | |
P/E GROWTH RATING 1..100 | 60 | 10 | |
SEASONALITY SCORE 1..100 | n/a | 21 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
UNH's Valuation (4) in the Managed Health Care industry is somewhat better than the same rating for CNC (61). This means that UNH’s stock grew somewhat faster than CNC’s over the last 12 months.
CNC's Profit vs Risk Rating (91) in the Managed Health Care industry is in the same range as UNH (96). This means that CNC’s stock grew similarly to UNH’s over the last 12 months.
UNH's SMR Rating (58) in the Managed Health Care industry is somewhat better than the same rating for CNC (95). This means that UNH’s stock grew somewhat faster than CNC’s over the last 12 months.
CNC's Price Growth Rating (6) in the Managed Health Care industry is somewhat better than the same rating for UNH (47). This means that CNC’s stock grew somewhat faster than UNH’s over the last 12 months.
UNH's P/E Growth Rating (10) in the Managed Health Care industry is somewhat better than the same rating for CNC (60). This means that UNH’s stock grew somewhat faster than CNC’s over the last 12 months.
| CNC | UNH | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 68% | 2 days ago 76% |
| Stochastic ODDS (%) | 2 days ago 76% | 2 days ago 65% |
| Momentum ODDS (%) | 2 days ago 62% | 2 days ago 54% |
| MACD ODDS (%) | 2 days ago 63% | 2 days ago 54% |
| TrendWeek ODDS (%) | 2 days ago 63% | 2 days ago 56% |
| TrendMonth ODDS (%) | 2 days ago 63% | 2 days ago 55% |
| Advances ODDS (%) | 2 days ago 61% | 11 days ago 56% |
| Declines ODDS (%) | 15 days ago 63% | 3 days ago 53% |
| BollingerBands ODDS (%) | 2 days ago 67% | 2 days ago 64% |
| Aroon ODDS (%) | 2 days ago 58% | 2 days ago 66% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CNC’s FA Score shows that 1 FA rating(s) are green while UNH’s FA Score has 2 green FA rating(s).
- CNC’s FA Score: 1 green, 4 red.
- UNH’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CNC’s TA Score shows that 5 TA indicator(s) are bullish while UNH’s TA Score has 5 bullish TA indicator(s).
- CNC’s TA Score: 5 bullish, 5 bearish.
- UNH’s TA Score: 5 bullish, 4 bearish.
Price Growth
CNC (@Managed Health Care) experienced а +7.96% price change this week, while UNH (@Managed Health Care) price change was +5.22% for the same time period.
The average weekly price growth across all stocks in the @Managed Health Care industry was +4.91%. For the same industry, the average monthly price growth was +0.91%, and the average quarterly price growth was +49.60%.
Reported Earning Dates
CNC is expected to report earnings on Oct 27, 2026.
UNH is expected to report earnings on Jan 20, 2027.
Industries' Descriptions
@Managed Health Care (+4.91% weekly)Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.
Advertisement
CNC and
Correlation & Price change
A.I.dvisor indicates that over the last year, CNC has been loosely correlated with ELV. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if CNC jumps, then ELV could also see price increases.
UNH and
Correlation & Price change
A.I.dvisor indicates that over the last year, UNH has been closely correlated with ELV. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if UNH jumps, then ELV could also see price increases.